Caribou Biosciences, INC Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
NASDAQ
SCHEDULE 13G/A: BlackRock Amends Passive Stake in Caribou Biosciences
BlackRock, Inc. has filed an amendment to its Schedule 13G, disclosing a 2.0% passive ownership stake in Caribou Biosciences, Inc. as of June 30, 2025.
NASDAQ
The Vanguard Group has filed an amendment to its Schedule 13G, disclosing a beneficial ownership of 4.86% in Caribou Biosciences Inc., indicating a passive investment below the 5% reporting threshold.
NASDAQ
BlackRock, Inc. has filed an amended Schedule 13G, revealing a 6.8% passive beneficial ownership stake in Caribou Biosciences, Inc. as of March 31, 2025.
NASDAQ
Bank of America Corporation has filed an amended Schedule 13G, disclosing a 2.2% passive beneficial ownership stake in Caribou Biosciences, Inc. as of December 31, 2024.